News | September 27, 2023
Hermes Pharma to invest €25 million to bolster manufacturing capabilities
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The market capitalization of the company stood at Rs. 7,000 crore +
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Subscribe To Our Newsletter & Stay Updated
